Liquid Biopsy Market Overview
As per the research report by MRFR, the global liquid biopsy market is projected to attain a size of approximately 17,372.28 million at a healthy CAGR of 28% during the forecast period
A liquid biopsy refers to a non-invasive sampling and analysis of liquid state biological tissue to detect and observe diseases such as cancer. The global liquid biopsy market has recorded praiseworthy growth in the past few years. The market’s growth is mainly credited to growing awareness regarding personalized cancer care. Furthermore, factors such as extensive research and development in cancer diagnosis and treatment, increasing prevalence of cancer, and increasing demand for non-invasive testing are also likely to positively impact the liquid biopsy market’s growth. On the other hand, tumor heterogeneity, considered the major challenge in cancer research, will likely impede the market’s growth over the coming years.
Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/710
Liquid Biopsy Market Segmentation
The global liquid biopsy market has been categorized into various segments based on application, end user, samples, biomarker types, and region.
Based on biomarker type, the global market for liquid biopsy is split into extracellular vehicles (EVS), circulating tumor DNA (CTDNA), circulating tumor cells (CTCS), and others.
The liquid biopsy market is divided into reproductive health, cancer, and others by application.
The global market for liquid biopsy is bifurcated into the forensic, urine sample, blood sample, and others based on the sample.
The global market is divided into academic & research centers, hospitals and laboratories, and others based on end-user.
Liquid Biopsy Market Regional Outlook
The global liquid biopsy market is studied across five major regions, including the Middle East & Africa, Asia-Pacific, Europe, North America, and South America.
The MRFR reports state that the North American region held the top position in the global liquid biopsy market in 2016, with the largest share of over 37.95%. The technology was developed in the U.S. that is seen in the region’s dominance globally.
The European regional liquid biopsy market will likely secure the second position globally over the assessment era. The regional market will exhibit a healthy CAGR of over 28.5%. The funding available in the market has doubled from 2001 to 2010. The presence of leading market players is the primary aspect causing an upsurge in the regional market’s growth.
The Saia-Pacific region is projected to register the highest growth rate of over 29.7% over the forecasted timeframe.
The liquid biopsy market for the Middle East & African region is projected to record the least growth over the assessment timeframe due to underdeveloped medical infrastructure.
Liquid Biopsy Market Competitive Analysis
The global liquid biopsy market has a strong and competitive landscape. The players in the global market are making heavy investments in research & development activities to offer innovative solutions to users worldwide. Furthermore, the players are focusing on growing their market presence across the globe by implementing several growth policies. The list of leading players in the global liquid biopsy market includes Exosome Diagnostics (Massachusetts), SAGA Diagnostics AB (Sweden), Circulogene Theranostics (Alabama), Biocept, Inc. KGaA (U.S.), Agena Bioscience Inc. (California), Trovagene, Inc. (California), Inivata Ltd (U.K.), Admera Health (U.S.), RainDance Technologies, Inc. (U.S.), Guardant Health, Inc. (U.S.), and several others.
May 2021- NeoGenomics jas announced its plans to acquire the remaining stake in Inivata for over USD390 million. NeoGenomics predicts the deal to get done by the middle of June. The transaction will offer NeoGenomics full ownership of InVisionFirst-Lung, a lung cancer panel, and the residual disease assay RaDaR.
Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/liquid-biopsy-market-710
January 2022 – An innovative biotechnology company, Progenity, Inc., has announced the patent regarding its single-molecule detection assay platform in progress. The USPTO has allotted U.S. Patent No. 11,230,731 titled, “Methods, Systems, and Compositions for Counting Nucleic Acid Molecules.”
October 2021 – An online marketplace for human biospecimens, iSpecimen Inc., has announced the expansion of its human biospecimen supplier network to provide progressively more comprehensive selections of whole blood, plasma, and other biofluids to boost the development of liquid biopsies.
Browse Related Reports at:
Dental Sleep Medicine Market Research Report Forecast to 2027
Respiratory Inhalers Market Research Report- Global Forecast To 2027
Population Health Management Market Research Report- Global Forecast To 2027
Intravenous Immunoglobulin (IVIg) Market Research Report Forecast To 2027
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 628 258 0071